ACIS ResearchAI Civilization Investment Research中文

INVESTMENT INTELLIGENCE · 014 · 2026.11.13

Vistra Enters Alpha Watch, but Post-Deal Leverage Still Blocks a Trial Upgrade

ACIS Investment Intelligence | Issue 014 | 13 November 2026

This is a Selection change, not a trading instruction. Weekly owns Evidence; Investment Intelligence owns Decision State. Better operations justify deeper research without bypassing Owner Cash, post-deal capital structure or valuation gates.

VistraVSTAlpha WatchPower DemandCogentrixOwner CashCapital Discipline

Public research | Full access

THE 10-SECOND VIEW

Vistra moves from sector evidence to Growth / Structural Alpha Watch, but not Trial. Q3 EBITDA, nine-month operating cash, 2027 guidance and long-term PPAs improve visibility into value capture. Acquisition payments, preferred redemption, assumed debt and non-GAAP cash definitions keep the full decision gate open.

The one-minute brief

The only Selection change this week is Vistra entering Alpha Watch. AI data-centre load makes dispatchable power scarcer, and Vistra's operating assets, PPAs and cash-flow guidance sit closer to revenue conversion than greenfield projects. The roughly 5.5GW Cogentrix acquisition also brings integration, interest and deleveraging requirements, while adjusted FCFbG cannot substitute for ordinary free cash flow or Owner Cash. Portfolio / Systemic remains Orange / Defense Review; no new QQQ Beta or SOXX / SMH risk is authorised.

Browser voice · tap to play
Audio transcript

Vistra enters Alpha Watch, but not Trial. Operating evidence is stronger while capital-structure evidence remains incomplete. Q3 adjusted EBITDA, operating cash, 2027 guidance and long-term PPAs show power demand beginning to convert into company economics. Cogentrix debt, interest, preferred redemption and Owner Cash still require reconciliation. Alpha Watch is a research list, not a buy instruction. Every real investment, trade or position change requires human approval.

01 · SCORE & MEASUREMENT

Evidence maturity, not expected return

States describe Selection and validation gates, not return probability, price target or trading authority.

Prior versus current research read
ModulePriorCurrentChange / Read
Portfolio / SystemicORANGE / DEFENSE REVIEWORANGE / DEFENSE REVIEWUnchanged
VistraEvidence PositiveALPHA WATCHSelection up; no Trial
QQQORANGE / NO NEW BETAORANGE / NO NEW BETAUnchanged
SOXX / SMHORANGE / NO NEW RISKORANGE / NO NEW RISKUnchanged
Market Psychology CurrentUNKNOWNUNKNOWNExpired readings not reused

02 · WHAT CHANGED

Evidence before narrative

1 | Why Alpha Watch now

Vistra reported Q3 adjusted EBITDA of $2.378bn and nine-month operating cash flow of $4.330bn, while introducing 2027 adjusted EBITDA guidance of $7.7–8.5bn and adjusted FCF-before-growth guidance of $4.3–5.1bn. Company-level evidence now warrants structured-power deep research.

2 | FCFbG is not Owner Cash

Adjusted FCFbG is a company-defined non-GAAP measure. It cannot automatically equal ordinary free cash flow or shareholder cash after interest, maintenance, acquisition consideration and other required capital obligations. The cash-flow bridge remains a separate test.

3 | Post-deal capital structure

The roughly 5.5GW Cogentrix acquisition closed in October. The September balance sheet predates closing, so purchase funding, preferred redemption, assumed debt, interest and integration need a fresh pro-forma bridge. Closing is not deleveraging.

4 | How data-centre PPAs create value

The 405MW Pulaski Solar project entered service under a Microsoft PPA, and Odessa signed a 20-year, 207MW PPA with New Era. Contracts improve demand visibility but still require availability, realised pricing, revenue, CFO and Owner Cash. A PPA is not fully recognised revenue.

5 | Why this is not Trial

Alpha Watch means the evidence merits deeper work. Trial still requires Owner Cash, post-deal leverage, contract conversion, valuation margin of safety and risk-adjusted return to pass together. Public evidence does not yet close every gate.

6 | Portfolio boundary

Portfolio / Systemic remains Orange / Defense Review. No new QQQ Beta or SOXX / SMH risk is authorised, and the state is not an automatic sale, hedge or liquidation. Every real action remains subject to Human Approval.

7 | Counterevidence and next tests

PPA delay, outages, adverse fuel or power prices, integration costs, rating pressure or repurchases that displace deleveraging would weaken the case. Falling net debt, durable Owner Cash, on-time contract ramp and a valuation margin of safety could reopen the Trial gate.

VALUE-CAPTURE MATRIX

One evidence chain, no double counting

From power demand to Selection
GateConfirmedStill open
EvidenceEBITDA, CFO, 2027 guide and PPAsDurability across cycles
Cash conversionOperating cash and company FCFbG guideOrdinary FCF, Owner Cash and required capital claims
Capital structureCogentrix closed with liquidity capacityPro-forma net debt, interest, integration and deleveraging
SelectionAlpha WatchTrial, Emerging and Confirmed remain closed
ActionHuman ReviewNo authority for real trades or positions

03 · THESIS → EVIDENCE → UPDATE

What the new evidence changes

Prior view

Vistra's operating evidence improved while Selection remained neutral.

New evidence

Cash flow, 2027 guidance, acquired assets and data-centre PPAs provide company-level cross-validation.

Updated view

Alpha Watch; Owner Cash, leverage and valuation continue to block Trial.

04 · NEXT VALIDATION

7D / 30D / 90D

Evidence checkpoints
WindowWhat to validate
7 daysComplete the Cogentrix pro-forma net-debt, interest and liquidity bridge.
30 daysValidate PPA ramp, availability, ordinary FCF and Owner Cash.
90 daysReview deleveraging, repurchase funding, incremental ROIC and valuation margin of safety.

FAQ

Questions readers should ask

Does Alpha Watch mean buy?

No. It means sustained deep research, not trading authority.

Why is FCFbG not ordinary free cash flow?

It is an adjusted company measure that must reconcile to the cash-flow statement, growth spending and capital claims.

Does AI data-centre demand guarantee Vistra returns?

No. Contracts, availability, cost, leverage, valuation and per-share cash returns can all change the outcome.

Did Decision State change?

VST Selection moves to Alpha Watch; the portfolio defense state is unchanged and no position action follows automatically.

KEY TERMS

Reader reference

Alpha Watch
A deep-research list where operating and valuation evidence has not reached the Trial review gate.
Owner Cash
Sustainable cash attributable to owners after maintenance, interest and other required capital claims.
FCFbG
Company-defined adjusted free cash flow before growth, requiring reconciliation to ordinary cash flow.

SOURCES & CONTINUITY

Verifiable sources

Continue reading

Evidence through 20:05 Beijing time on 13 November 2026. The public edition contains directional Decision State, public facts and Human Approval boundaries only. It excludes real holdings, costs, trade plans, internal sizing rules, private valuation sensitivities, client data, prompts and credentials. Not investment advice.